Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin–angiotensin–aldosterone system on COVID-19 disease

Table 1 Excerpt of patient characteristics that led to the COVID-19 WHO scale

	Age	Sex	BMI	Initial spO2 (O₂⁻)	Initial spO2 (O₂⁺)	RR (Sys)	RR (dias)	MAD	High-Flow in the course?	Intubation in the course?	HF (min)	AF (min)	Days of hospitalization
1	53	w	24.2	94	0	105	66	79	No	No	70	14	8
2	79	m	33,59	86	94 (2 l/min)	107	64	78	Yes	Yes	98	16	3
3	78	m	36,7	88	91 (2 l/min)	100	90	93	Yes	Yes	68	20	2
4	75	w	30,4	85	90 (2 l/min)	120	80	93	No	No	84	17	4
5	52	m	38,5	92	95 /2 l/min)	130	76	94	No	No	80	17	8
6	63	m	//	88	96 (2 l/min)	130	82	98	No	No	81	17	10
7	59	m	34,14	//	91 (3 l/min)	147	95	112	Yes	Yes	97	14	16

	Days until hospotalization	Arterial hypertension	ACE- or AT1-blocker	Cardiovascular diseases	Diabetes mellitus	Active tumor disease	Pulmonary diseases	Liver diseases	Chronic kidney diseases	Further disease	COVID-19	COVID-19
	Days until hospotalization	Arterial hypertension	ACE- or AT1-blocker	Cardiovascular diseases	Diabetes mellitus	Active tumor disease	Pulmonary diseases	Liver diseases	Chronic kidney diseases	Further disease	WHO-score	WHO-scale
1	9	No	No	No	No	No	No	No	No	Yes	4	Hospitalised moderate
2	8	No	Yes	Yes	Yes	No	Yes	No	Yes	Yes	8	Hospitalised severe
3	4	Yes	Yes	Yes	No	No	Yes	No	No	Yes	8	Hospitalised severe
4	14	Yes	Yes	No	Yes	No	No	No	No	Yes	5	Hospitalised moderate
5	5	No	No	No	Yes	No	No	No	No	No	5	Hospitalised moderate
6	6	No	No	No	No	No	No	No	No	No	5	Hospitalised moderate
7	10	Yes	Yes	Yes	Yes	No	No	No	No	Yes	8	Hospitalised severe

ISSN: 1743-422X